共 71 条
- [1] Shields CL(2006)The international classification of retinoblastoma predicts chemoreduction success Ophthalmology 113 2276-2280
- [2] Mashayekhi A(2009)Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes Ophthalmology 116 544-551
- [3] Au AK(2011)Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds Arch Ophthalmol 129 1399-1406
- [4] Czyz C(2012)Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results Br J Ophthalmol 96 499-502
- [5] Leahey A(2012)Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications Br J Ophthalmol 96 1078-1083
- [6] Meadows AT(2012)Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma Arch Ophthalmol 130 1268-1271
- [7] Shields JA(2014)Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results JAMA Ophthalmol 132 319-325
- [8] Shields CL(2012)Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track Br J Ophthalmol 96 1084-1087
- [9] Ramasubramanian A(2014)Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review Br J Ophthalmol 98 292-297
- [10] Thangappan A(2014)Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma JAMA Ophthalmol 132 936-941